Literature DB >> 22120687

Quantification and localization of contrast agents using delta relaxation enhanced magnetic resonance at 1.5 T.

Uvo Christoph Hoelscher1, Steffen Lother, Florian Fidler, Martin Blaimer, Peter Jakob.   

Abstract

OBJECT: Delta relaxation enhanced magnetic resonance (dreMR) is a new imaging technique based on the idea of cycling the magnetic field B (0) during an imaging sequence. The method determines the field dependency of the relaxation rate (relaxation dispersion dR (1)/dB). This quantity is of particular interest in contrast agent imaging because the parameter can be used to determine contrast agent concentrations and increases the ability to localize the contrast agent.
MATERIALS AND METHODS: In this paper dreMR imaging was implemented on a clinical 1.5 T MR scanner combining conventional MR imaging with fast field-cycling. Two improvements to dreMR theory are presented describing the quantification of contrast agent concentrations from dreMR data and a correction for field-cycling with finite ramp times.
RESULTS: Experiments demonstrate the use of the extended theory and show the measurement of contrast agent concentrations with the dreMR method. A second experiment performs localization of a contrast agent with a significant improvement in comparison to conventional imaging.
CONCLUSION: dreMR imaging has been extended by a method to quantify contrast agent concentrations and improved for field-cycling with finite ramp times. Robust localization of contrast agents using dreMR imaging has been performed in a sample where conventional imaging delivers inconclusive results.

Mesh:

Substances:

Year:  2011        PMID: 22120687     DOI: 10.1007/s10334-011-0291-6

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  5 in total

1.  Determination of the MRI contrast agent concentration time course in vivo following bolus injection: effect of equilibrium transcytolemmal water exchange.

Authors:  C S Landis; X Li; F W Telang; J A Coderre; P L Micca; W D Rooney; L L Latour; G Vétek; I Pályka; C S Springer
Journal:  Magn Reson Med       Date:  2000-10       Impact factor: 4.668

2.  Evidence for a contribution of paramagnetic ions to water proton spin-lattice relaxation in normal and malignant mouse tissues.

Authors:  W Negendank; T Corbett; M Crowley; C Kellogg
Journal:  Magn Reson Med       Date:  1991-04       Impact factor: 4.668

3.  Delta relaxation enhanced MR: improving activation-specificity of molecular probes through R1 dispersion imaging.

Authors:  Jamu K Alford; Brian K Rutt; Timothy J Scholl; William B Handler; Blaine A Chronik
Journal:  Magn Reson Med       Date:  2009-04       Impact factor: 4.668

4.  Magnetic resonance imaging with T1 dispersion contrast.

Authors:  Sharon E Ungersma; Nathaniel I Matter; Jonathan W Hardy; Ross D Venook; Albert Macovski; Steven M Conolly; Greig C Scott
Journal:  Magn Reson Med       Date:  2006-06       Impact factor: 4.668

Review 5.  Molecular imaging with targeted contrast agents.

Authors:  Marcus R Makowski; Andrea J Wiethoff; Christian H P Jansen; René M Botnar
Journal:  Top Magn Reson Imaging       Date:  2009-08
  5 in total
  3 in total

1.  Eddy current compensation for delta relaxation enhanced MR by dynamic reference phase modulation.

Authors:  Uvo Christoph Hoelscher; Peter M Jakob
Journal:  MAGMA       Date:  2012-08-24       Impact factor: 2.310

2.  Quantitative vascular neuroimaging of the rat brain using superparamagnetic nanoparticles: New insights on vascular organization and brain function.

Authors:  Codi A Gharagouzloo; Liam Timms; Ju Qiao; Zihang Fang; Joseph Nneji; Aniket Pandya; Praveen Kulkarni; Anne L van de Ven; Craig Ferris; Srinivas Sridhar
Journal:  Neuroimage       Date:  2017-09-06       Impact factor: 6.556

3.  Joint multi-field T1 quantification for fast field-cycling MRI.

Authors:  Markus Bödenler; Oliver Maier; Rudolf Stollberger; Lionel M Broche; P James Ross; Mary-Joan MacLeod; Hermann Scharfetter
Journal:  Magn Reson Med       Date:  2021-06-10       Impact factor: 4.668

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.